Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sangzhi total alkaloids tablets in type 2 diabetes (phase III)
CTR20140569Phase 3Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramulus mori alkaloids in type 2 diabetes mellitus (T2DM), sponsored by Shanghai Institute of Materia Medica. Started Sep 2014; status: completed.
02
Drugs
ramulus mori alkaloids
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20140569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140569.